Form 4 for ALT Altimmune, Inc.
Accepted 2023-08-15 00:00:00 ET · period of report 2023-08-15 · accession 0001104659-23-092080 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-08-15 | 2023-08-15 | ALT | Drutz David | Dir | P - Purchase | $2.88 | +300 | 29.8K | +1% | +$864 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 | 2023-08-15 | P | A | 300 | $2.88 | 29,785 | I See Footnote | — | — | (F1) Represents Common Stock purchased and immediately transferred to Pacific Biopharma Associates, LLC. (F2) Represents Common Stock held by Pacific Biopharma Associates, LLC, of which the reporting person is the President. |